Alagra

Clinical Trials

Fexofenadine has undergone extensive clinical trials demonstrating its efficacy and safety for treating seasonal allergic rhinitis and chronic idiopathic urticaria across various populations, including children and adults.

Lab Monitoring

• No specific routine lab monitoring is required for fexofenadine.

Doctor Notes

• Emphasize patient education regarding fruit juice interactions and antacid separation.
• Advise patients that while non-sedating, individual responses to antihistamines can vary.
• Review renal function in elderly or renally impaired patients before prescribing.

Patient Guidelines

• Take Alagra exactly as prescribed by your doctor.
• Avoid taking Alagra with fruit juices (grapefruit, orange, apple).
• Inform your doctor about all other medications you are taking, especially antacids.
• If symptoms do not improve or worsen, consult your doctor.

Missed Dose Advice

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to make up for a missed one.

Driving Precautions

Although Alagra is a non-sedating antihistamine, individual responses can vary. Patients should assess their response before engaging in activities requiring mental alertness, such as driving or operating machinery.

Lifestyle Advice

• Identify and avoid allergens that trigger your symptoms.
• Maintain good hydration.
• Avoid alcohol consumption as it may enhance drowsiness, although fexofenadine is generally non-sedating.